Barrioz 1994.
Methods | Generation of the allocation sequence: method unclear. Allocation concealment: method unclear. Blinding: Not blinded. Intention‐to‐treat: not stated. Exclusions from analysis: not stated. Follow up period: unclear. Jadad‐score: 2. | |
Participants | Twenty patients with malignant biliary stricture and endoscopically inserted biliary polyethylene stent. | |
Interventions | Ursodeoxycholic acid (13‐15 mg/kg/d) and norfloxacin (400 mg/d) versus no treatment. | |
Outcomes | Duration of stent patency. Mortality. Duration of hospitalisation. | |
Notes | Cholangiocarcinoma was more common in the drug treated group. | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Allocation concealment? | Unclear risk | B ‐ Unclear |